left space About Us Product Candidates Newsroom Investor Information Business Development

IDDS logo
c Investors Information
left space Overview   Governance   SEC Filings   News Releases   Events   Email Notification   Investor Kit    Snapshot

pixel shim

Press Releases

 
 
9/18/2007
Javelin Pharmaceuticals to Present at Think Equity Partners Fifth Annual Growth Conference in San Francisco
PDF 7.2 KB
9/6/2007
Javelin Pharmaceuticals CEO to Provide Corporate Overview and Updates on Dyloject(TM) and PMI-150 at BioCentury NewsMakers Conference
PDF 11.9 KB
8/9/2007
Javelin Pharmaceuticals Reports Second Quarter 2007 Results
PDF 13.2 KB
8/3/2007
Javelin Pharmaceuticals to Host Quarterly Conference Call
PDF 8.0 KB
7/31/2007
Javelin Pharmaceuticals Initiates Phase 3 Breakthrough Cancer Pain Trial for Intranasal Ketamine
PDF 10.0 KB
7/26/2007
Javelin Pharmaceuticals Begins Second Phase 3 Study of Dyloject(TM)
PDF 8.5 KB
6/27/2007
Javelin Pharmaceuticals to Host Conference Call on Recent Major Milestones
PDF 8.3 KB
6/25/2007
Javelin Pharmaceuticals Joins Russell 2000(R), 3000(R), Microcap(TM) and Global Indexes
PDF 9.1 KB
6/19/2007
Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial Data
PDF 9.3 KB
6/13/2007
Javelin Pharmaceuticals' Dyloject(TM) Gains an Additional 10 Years of Patent Protection with Issuance of New European Patent
PDF 8.4 KB
6/5/2007
Javelin Pharmaceuticals Phase II Rylomine(TM) (Intranasal Morphine) Data Published in Pain Medicine
PDF 8.7 KB
5/24/2007
Javelin Pharmaceuticals to Present at the Citigroup 2007 Healthcare Conference
PDF 7.0 KB
5/22/2007
Javelin Pharmaceuticals Signs Commercial Supply Agreement with Baxter Healthcare Corporation
PDF 7.9 KB
5/11/2007
Javelin Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
PDF 7.7 KB
5/9/2007
Javelin Pharmaceuticals, Inc. Files Form 10-K/A Reinserting Previously Disclosed Explanatory Footnote.
PDF 7.7 KB
5/2/2007
Javelin Pharmaceuticals, Inc. Announces Public Stock Offering
PDF 7.0 KB
5/1/2007
Javelin Pharmaceuticals, Inc. Reports First Quarter 2007 Results
PDF 11.0 KB
3/19/2007
Javelin Pharmaceuticals Reports Results for The Year Ended 2006
PDF 12.7 KB
3/13/2007
Javelin Pharmaceuticals to Present at Cowen & Company 27th Annual Health Care Conference
PDF 6.8 KB
3/6/2007
Javelin Pharmaceuticals Granted MHRA Wholesale Dealer's License for UK Medicinal Products
PDF 7.3 KB
 
Showing 81-100 of 156 releases Page: 1 2 3 4 5 6 7 8  See Previous 20 | See Next 20
 

 

CONTACT US   JOIN US   SITE MAP
© 2010 Javelin Pharmaceuticals,Inc. / Intrac,Inc. / IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.